Genentech lines up a new autoimmune R&D alliance on a 'potentially transformative' tech
Parvus Therapeutics has just scored a discovery deal with Genentech on autoimmune diseases, putting them in alliance with one of the most sought-after partners in …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
